In summary, our results support the conclusion that these proteins (i.e., SPP1, ATP6V0D2, CHI3L1, and BDNF) likely play important roles in the development of atherosclerosis-related diseases and further indicate that they are potential diagnostic and therapeutic biomarkers. This evidence concerns the gene CHI3L1 and atherosclerosis.